Hong Kong said on Wednesday it had approved the baby version of the BioNTech COVID-19 vaccine for babies and children under five years old, part of broader measures to boost vaccination uptake in the financial hub.
Hong Kong said on Wednesday it had approved the baby version of the BioNTech COVID-19 vaccine for babies and children under five years old, part of broader measures to boost vaccination uptake in the financial hub.